Greg Walters Email and Phone Number
Greg Walters work email
- Valid
- Valid
Greg Walters personal email
Greg Walters phone numbers
President/CEO of Excision Medical, a startup company dedicate to advance the field of heart leaflet modification for therapeutic gains during structural heart treatments. Former President/CEO and co-founder of Essential Medical, acquired by Teleflex in 2018.35 year product development professional with extensive experience with designing, developing, and commercializing interventional cardiology products including embolic protection devices, atherectomy catheters, thrombectomy and extraction catheters, chronic total occlusion catheters and femoral closure devices. Experienced with 510K, PMA and Class II and III devices, including all aspects of clinical trials and regulatory submission. Listed inventor on 75+ US and European patents/applications.
-
Chief Executive OfficerExcision Medical, Inc. Oct 2021 - PresentStructural heart startup focused on heart leaflet modification technologies.
-
Vp Of Access And ClosureTeleflex Incorporated Oct 2018 - Oct 2019Wayne, Pa, UsTransitioned MANTA and the Essential Medical team to Teleflex. -
President And CeoEssential Medical, Inc. May 2010 - Oct 2018Exton, Pa, UsVascular closure startup focused on creating novel Large Bore closure systems for femoral access. -
Vp Of Product DevelopmentKensey Nash Corporation Nov 2001 - Nov 2009Led the product development and commercialization of the TriActiv system, supported US clinical studies, gained CE-mark and 510(k) approvals. Developed a local extraction version of TriActiv for use in Carotid arteries. Secured approval and supported US carotid study (PROGUARD) and secured CE mark. Supervised the development of the QuickCat Extraction Catheter, a class-leading aspiration catheter indicated for use for the removal of soft thrombus in the arterial system. Gained US and European approvals. Supervised the development of the ThromCat Thrombus Removal System from concept through European clinical studies and US and European commercialization. Performed due diligence and design assumption activities for the Safe-Cross OCR Chronic Total Occlusion System acquired from Intraluminal Therapeutics. Supervised subsequent development activities. Key managerial role in the divesting of the KNC Endovascular platform (ThromCat, QuickCat and SafeCross) to Spectranetics Corporation for $24 million in May 2007. Identified and participated in business development activities related to opportunities with filters, thrombectomy devices, access catheters, orthopedic, and bariatric surgery instruments.
-
Director Of Product DevelopmentKensey Nash Corporation Sep 1994 - Nov 2001Managed Angio-Seal R&D activities jointly sponsored by Kensey Nash Corporation and its licensees. Developed winning 6F version. Redesigned the device to be more efficacious and easier to use. Successfully navigated difficult technical, manufacturing, and regulatory issues. Managed the Aegis Vortex program, a device designed to perform protected debulking of SVG lesions.
-
Senior R & D EngineerKensey Nash Corporation Sep 1993 - Sep 1994Key team member during development of the Angio-Seal device. Managed a 10F version of the product. Personally performed sterile surgical procedures and implants. Conducted multiple major design reviews.
-
Development EngineerKensey Nash Corporation Jan 1992 - Sep 1993Medical device design, including biocompatibility, resorption studies, radiopaque fillers in resorbable materials, collagen production process for Angio-Seal collagen.
-
Electro-Optics EngineerGeneral Electric Company May 1988 - Jan 1992Boston, Ma, UsDesigned and built a 150W carbon-monoxide (CO) gas discharge laser for use in laser survivability testing. Conducted laser survivability testing for satellite programs. Graduate of GE's corporate engineering program. Completed extensive leadership training (PLCI and PLCII) and four job rotations. -
Edison EngineerGe 1986 - 1988Boston, Ma, UsParticipated in GE's Advanced Engineering/Leadership Development Programs
Greg Walters Skills
Greg Walters Education Details
-
Penn State UniversityManagement -
Millersville University Of PaPhysics
Frequently Asked Questions about Greg Walters
What company does Greg Walters work for?
Greg Walters works for Excision Medical, Inc.
What is Greg Walters's role at the current company?
Greg Walters's current role is President/CEO/Founder Excision Medical.
What is Greg Walters's email address?
Greg Walters's email address is gr****@****ast.net
What is Greg Walters's direct phone number?
Greg Walters's direct phone number is +161055*****
What schools did Greg Walters attend?
Greg Walters attended Penn State University, Millersville University Of Pa.
What are some of Greg Walters's interests?
Greg Walters has interest in Poverty Alleviation, Health.
What skills is Greg Walters known for?
Greg Walters has skills like Medical Devices, Design Control, Iso 13485, Fda, Product Development, R&d, Manufacturing, Leadership, Commercialization, Market Development, Cross Functional Team Leadership, Surgery.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial